Androgenetic Alopecia at Various Ages and Prostate Cancer Risk in an Equal Access Multiethnic Case Control Series of Veterans

    April 2012 in “ The Journal of Urology ”
    Jean-Alfred Thomas, Jodi Antonelli, Lionel L. Bañez, Leah R. Gerber, Cathrine Hoyo, Delores J. Grant, Wendy Demark-Wahnefried, Elizabeth A. Platz, Elizabeth Calloway, Enwono Eyoh, Kathleen H. Shuler, Stephen J. Freedland
    Image of study
    TLDR Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.
    This document contains three studies related to prostate cancer. The first study examined the relationship between androgenetic alopecia (AA) and prostate cancer risk in a multiethnic cohort of veterans. The results showed that men reporting earlier onset of AA were at increased risk for prostate cancer and suggestively had more aggressive disease. The second study compared the incidence of second malignancy development after external-beam radiotherapy (EBRT) and brachytherapy (BRT) for prostate cancer and found that the incidence of second malignancy after prostate cancer radiotherapy was not significantly different than surgery when adjusted for age of the patient and prior smoking history. The third study conducted a meta-analysis to determine the association between dietary omega-3 and omega-6 fatty acids with prostate cancer risk from prospective studies. The results showed that high intake of alpha-linolenic acid (ALA) may reduce the risk of prostate cancer, while intake of long-chain n-3 PUFA and n-6 PUFA do not significantly affect the risk of prostate cancer.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 1000+ results

      community How do we only have two treatments to combat hair loss at this point in time?

      in Chat  211 upvotes 1 year ago
      The post discusses frustration over the limited and not always effective treatments for hair loss, mainly Minoxidil and Finasteride. The conversation includes mentions of potential new treatments like GT20029, HMI-115, CosmeRNA, KX-826, and microneedling, but also highlights the challenges of funding and prioritizing research in this area.

      community 35% regrowth brothers and sisters! More effective than Minox and Fin?

      in Treatment  107 upvotes 6 years ago
      A double-blind clinical study that found ingestion of tocotrienols resulted in a 34.5% increase in hair regrowth compared to the placebo group, and discussion about potential side effects and cost of supplementation with vitamin E pills. The conversation noted that it may be more effective than commonly used treatments like minoxidil and finasteride.

      community How many of you have significant others?

      in Shaved/buzzed  105 upvotes 1 year ago
      The conversation revolves around the experiences of different individuals with hair loss treatments like Minoxidil, Finasteride, and RU58841. The discussion includes various perspectives on the effects of these treatments, the importance of hair for self-esteem and attractiveness, and the influence of significant others on the decision to use or stop using these treatments.

    Similar Research

    5 / 1000+ results